Journal
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Volume 26, Issue 8, Pages 733-739Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/cap.2015.0149
Keywords
ghrelin; insulin resistance; adipocytokine; depression; sertraline
Categories
Funding
- Ondokuz Mayis University, Project Management Office [PYO.TIP.1901.14.008]
Ask authors/readers for more resources
Objective: One of the hypotheses of the pathophysiology of major depressive disorder (MDD) proposes that there is a relationship between adipocytokine and ghrelin levels and depression. Methods: Patients with major depression with a BMI 25kg/m(2) between the ages of 11 and 18 years (n=30) were compared with a healthy control group (n=30). Both groups were evaluated across a pretreatment period (MD-PT) and an improved period (MD-I). We measured serum leptin, adiponectin, resistin, and ghrelin levels and other parameters related to metabolic syndrome, such as glucose, insulin, insulin resistance (homeostasis model assessment [HOMA]), triglycerides (TG), and total cholesterol (TCHOL). Results: Leptin, adiponectin, and resistin levels did not differ across groups; however, ghrelin levels were increased in the MD-I group compared with the control and MD-PT groups (p<0.05). HOMA levels were also higher in the MD-PT group than in the control group (p<0.05). After treatment, there was no difference in this measurement. Conclusions: The relationship between adipocytokines and major depression may be dependent on ghrelin levels as a result of antidepressant treatment and subsequent obesity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available